Correspondence, A. Scribner of Winthrop-Stearns Inc. to C. Walton Lillehei regarding Isuprel

http://gallery.lib.umn.edu/archive/original/4168ba40c87583298a861979eb565fbb.jpg
http://gallery.lib.umn.edu/archive/original/251b52b0ea1570d265934506920d02d8.pdf

Dublin Core

Title

Correspondence, A. Scribner of Winthrop-Stearns Inc. to C. Walton Lillehei regarding Isuprel

Subject

Open Heart Surgery

Description

In 1955, C. Walton Lillehei began to administer a new drug named Isuprel to treat patients that developed heart block following an open heart surgery.

Creator

A. Scribner

Source

"Winthrop-Stearns Laboratory, Isuprel, 1955-1967," Box 100, C. Walton Lillehei papers, uarc2000-7, University of Minnesota Archives

Publisher

University of Minnesota

Date

19-Oct-55

Contributor

C. Walton Lillehei

Rights

Use of this image is governed by U.S. and international copyright laws. Image is property of the University of Minnesota. Please contact the University of Minnesota Archives for permission to publish this image. http://special.lib.umn.edu/uarch

Format

Document

Language

eng

Identifier

oh0286

Coverage

Open Heart Surgery

Text Item Type Metadata

Original Format

Paper

Citation

A. Scribner, “Correspondence, A. Scribner of Winthrop-Stearns Inc. to C. Walton Lillehei regarding Isuprel,” Gallery, accessed January 31, 2023, http://gallerytemp.reclaim.hosting/items/show/3284.

Document Viewer